Zim Laboratories

Zim Laboratories

75.65
-0.29
(-0.38%)
Market Cap
370.00 Cr
EPS
2.50
PE Ratio
39.38
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
128.90
52 Week Low
69.10
PB Ratio
1.48
Debt to Equity
0.47
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,578.70
#1 3,75,543.90
32.72
#1 54,729.00
9.71
#1 10,980
-19.84
38.34
6,164.00
1,62,480.00
70.47
9,712.00
18.67
2,191
26.74
45.46
1,578.40
1,26,745.50
23.50
28,409.50
7.12
5,291
9.88
57.88
3,606.70
1,21,261.60
60.06
11,539.40
6.99
1,911
19.91
52.56
2,559.10
1,04,969.30
55.52
12,744.20
#1 20.90
2,007
-18.14
54.70
1,262.20
1,04,630.20
#1 18.47
33,741.20
16.73
5,725
1.26
51.17
1,008.20
1,00,231.00
21.50
23,511.00
18.55
4,615
2.60
59.39
1,951.10
86,301.70
23.32
22,909.50
13.74
3,306
#1 51.64
53.04
32,575.00
69,049.60
47.34
6,684.70
9.64
1,414
11.55
48.94
5,292.00
62,729.80
27.60
13,458.30
3.70
2,216
21.39
57.00

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
3.27 %
Net Income Growth
-29.07 %
Cash Flow Change
152.76 %
ROE
-33.24 %
ROCE
-9.59 %
EBITDA Margin (Avg.)
3.13 %

Quarterly Financial Results

Quarterly Financials
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
64
64
75
79
71
72
99
95
69
68
74
72
71
88
76
75
65
78
87
107
95
101
103
106
69
87
97
119
83
94
98
110
73
Expenses
57
55
64
62
62
61
85
84
64
63
65
62
60
81
67
65
59
67
76
90
82
87
88
90
63
77
85
102
74
83
85
94
68
EBITDA
7
9
11
17
9
11
13
11
4
5
9
9
11
8
8
10
7
11
11
16
13
14
16
16
6
11
13
17
9
11
13
16
6
Operating Profit %
11 %
13 %
15 %
13 %
12 %
14 %
13 %
11 %
5 %
7 %
11 %
10 %
15 %
9 %
10 %
12 %
8 %
13 %
12 %
14 %
12 %
12 %
13 %
15 %
7 %
11 %
12 %
13 %
10 %
10 %
12 %
13 %
6 %
Depreciation
2
2
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
4
4
4
4
5
4
4
4
4
5
5
5
5
5
Interest
2
3
2
3
3
3
3
3
3
3
3
3
3
3
2
3
3
3
2
1
1
1
2
1
2
1
2
2
3
3
3
3
3
Profit Before Tax
3
4
7
11
4
5
8
5
-2
-2
2
3
4
1
2
3
0
4
6
11
8
8
10
10
0
5
7
11
1
3
6
8
-2
Tax
1
1
1
3
0
1
2
3
-3
-1
0
0
1
0
1
1
0
1
2
4
2
3
3
3
0
1
2
3
0
1
2
3
-1
Net Profit
2
3
6
8
4
3
6
2
0
-1
2
2
3
1
1
2
0
3
4
7
5
5
7
7
0
4
5
8
1
2
4
5
-2
EPS in ₹
2.66
1.79
7.81
4.84
2.35
2.08
3.65
1.43
0.05
-0.37
0.94
1.41
2.02
0.73
0.80
0.95
0.12
2.00
2.51
4.33
3.17
3.35
1.35
1.48
0.05
0.85
0.98
1.66
0.18
0.49
0.82
1.01
-0.38

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
265
256
259
298
329
325
325
342
342
447
472
Fixed Assets
87
92
89
94
106
116
107
106
109
161
164
Current Assets
168
154
154
173
194
182
192
212
191
228
231
Capital Work in Progress
6
3
4
8
13
10
11
12
27
42
71
Investments
0
0
0
0
0
0
0
0
0
0
0
Other Assets
172
161
166
196
209
200
208
224
206
244
237
Total Liabilities
265
256
259
298
329
325
325
342
342
447
472
Current Liabilities
133
122
113
141
155
143
142
146
111
159
166
Non Current Liabilities
38
35
28
20
22
28
22
20
30
49
53
Total Equity
94
99
118
137
151
154
161
176
200
239
252
Reserve & Surplus
86
91
110
129
135
138
145
160
152
190
202
Share Capital
8
8
8
8
16
16
16
16
49
49
49

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
-7
-0
-0
1
-1
1
-0
2
3
3
-8
Investing Activities
-9
-12
-7
-26
-21
-19
-6
-14
-36
-73
-40
Operating Activities
6
22
32
37
35
22
32
49
38
16
41
Financing Activities
-4
-10
-25
-10
-15
-2
-26
-33
1
60
-9

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
33.26 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.00 %
0.00 %
0.21 %
0.01 %
0.03 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.11 %
0.10 %
0.24 %
0.24 %
0.24 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
30.73 %
51.92 %
51.96 %
50.67 %
50.77 %
51.15 %
50.96 %
51.57 %
51.57 %
49.90 %
50.74 %
50.92 %
49.01 %
49.21 %
45.48 %
44.39 %
47.78 %
47.50 %
Others
36.01 %
14.81 %
14.77 %
16.06 %
15.97 %
15.59 %
15.78 %
15.17 %
15.16 %
16.84 %
15.99 %
15.82 %
17.72 %
17.42 %
21.15 %
21.90 %
18.71 %
18.96 %
No of Share Holders
4,600
4,887
4,610
3,646
3,561
3,569
3,643
5,595
5,879
8,982
15,305
17,342
17,100
17,483
17,716
17,450
17,448
16,641

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
BONUS Bonus
1:1
04 Oct 2018 55.33 0.00
29 Jun 2022 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
29 Jun 2022 77.67 63.50
22 Dec 2022 BONUS Bonus
2:1
22 Dec 2022 105.18 110.83
27 Jun 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Jun 2024 102.30 105.00
09 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Nov 2024 106.99 113.35
10 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Feb 2025 101.05 106.72
20 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
20 May 2025 88.41 92.99
27 Jun 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
27 Jun 2025 88.14 112.62
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 111.70 79.30

Announcements

Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 07, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 07, 2025
Disclosure Under Regulation 30 Of The SEBI (LODR) Regulations 2015Aug 07, 2025
Announcement under Regulation 30 (LODR)-AcquisitionAug 07, 2025
Results- Financial Results For Quarter Ended 30Th June 2025Aug 07, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 07Th August 2025Aug 07, 2025
Reply To Clarification Sought On Price MovementAug 07, 2025
Clarification Sought On Movement Of Price Of The CompanyAug 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 06, 2025
Clarification sought from Zim Laboratories LtdAug 06, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 04, 2025
Announcement Under Regulation 30 Of The SEBI (LODR) Regulations 2015Aug 01, 2025
Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended 30Th June 2025.Jul 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 22, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 21, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJul 11, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJun 27, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJun 27, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionJun 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2025
Reg. 34 (1) Annual Report.Jun 05, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 04, 2025
Announcement Under Regulation 30 - Letters Sent To ShareholdersJun 03, 2025
Notice Of The 41St Annual General Meeting Of The CompanyJun 03, 2025
Reg. 34 (1) Annual Report.Jun 03, 2025
Intimation Of Annual General Meeting To Be Held On Intimation Of Date Of Annual General MeetingJun 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 29, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 22, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 22, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 21, 2025
Q4 & FY25 - Earnings PresentationMay 20, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 20, 2025
Results - Financials For The Quarter And Year Ended 31St March 2025May 20, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On 20.05.2025May 20, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 14, 2025
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results For The Quarter And Year Ended 31St March 2025May 14, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMay 08, 2025
Outcome Of Board MeetingApr 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 09, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMar 28, 2025

Technical Indicators

RSI(14)
Neutral
35.34
ATR(14)
Less Volatile
3.86
STOCH(9,6)
Neutral
56.37
STOCH RSI(14)
Overbought
98.07
MACD(12,26)
Bullish
1.15
ADX(14)
Strong Trend
49.78
UO(9)
Bearish
43.47
ROC(12)
Uptrend And Accelerating
1.12
WillR(14)
Neutral
-36.67